Literature DB >> 6125160

Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.

R F Alvares, J F Goodwin.   

Abstract

Beta adrenergic blocking drugs in hypertrophic cardiomyopathy provide symptomatic relief but their effect on long-term prognosis is uncertain. Thirty patients were studied non-invasively by simultaneous recordings of echocardiogram, apex-cardiogram, phonocardiogram, and electrocardiogram in order to assess diastolic abnormalities on and off oral beta adrenergic blocking drugs. While on treatment these patients had a mean dose of propranolol 200 mg/day. The treatment was stopped for one week and then non-invasive assessment was repeated. The following diastolic time intervals were studied: isovolumic relaxation period (A2-mitral valve opening); rapid relaxation period (A2-O point of the apexcardiogram), and the period from mitral valve opening to the O point of the apexcardiogram (Mo-O) when most of the filling of the left ventricle occurs. The prolongation of the rapid relaxation period reflects a reduced rate of fall of the left ventricular pressure when the pressure differential does not change between A2 and the O point of the apexcardiogram, and in this study this period was prolonged in 19, shortened in eight, and remained the same in three patients after beta blockade. The Mo-O point was prolonged in 22, shortened in seven, and was unchanged in one patient after beta adrenergic blocking drugs. All these results were independent of heart rate. In conclusion the response of diastolic time intervals to beta blocking drugs in hypertrophic cardiomyopathy was variable but there was a significant number of patients in whom the time available for filling of the left ventricle was prolonged, suggesting better filling possibly because of improved distensibility of the left ventricle after beta adrenergic blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125160      PMCID: PMC481230          DOI: 10.1136/hrt.48.3.204

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  21 in total

1.  Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.

Authors:  P J Hubner; G M Ziady; G K Lane; T Hardarson; B Scales; C M Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1973-11

Review 2.  The cardiomyopathies.

Authors:  J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1972-06

3.  Left ventricular dimensions and dynamics of filling in patients with gallop heart sounds.

Authors:  C M Porter; W A Baxley; E E Eddleman; M Frimer; C E Rackley
Journal:  Am J Med       Date:  1971-06       Impact factor: 4.965

4.  Measurement of instantaneous left ventricular dimension and filling rate in man, using echocardiography.

Authors:  D G Gibson; D Brown
Journal:  Br Heart J       Date:  1973-11

5.  Left ventricular pressure-dimension relationships in the conscious dog.

Authors:  L D Horwitz; V S Bishop
Journal:  Cardiovasc Res       Date:  1972-03       Impact factor: 10.787

6.  Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis.

Authors:  P M Shah; R Gramiak; A G Adelman; E D Wigle
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

7.  Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy.

Authors:  D A Swan; B Bell; C M Oakley; J Goodwin
Journal:  Br Heart J       Date:  1971-09

8.  Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis.

Authors:  R L Popp; D C Harrison
Journal:  Circulation       Date:  1969-12       Impact factor: 29.690

Review 9.  Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications.

Authors:  S E Epstein; E Braunwald
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

Review 10.  Treatment of the cardiomyopathies.

Authors:  J F Goodwin
Journal:  Am J Cardiol       Date:  1973-09-07       Impact factor: 2.778

View more
  9 in total

Review 1.  Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.

Authors:  Georgios K Efthimiadis; Efstathios D Pagourelias; Thomas Gossios; Thomas Zegkos
Journal:  World J Cardiol       Date:  2014-02-26

2.  Muscle dynamics in hypertrophic cardiomyopathy.

Authors:  R F Alvares; J F Goodwin
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

3.  Respiratory modulation of cardiac time intervals.

Authors:  P Van Leeuwen; H C Kuemmell
Journal:  Br Heart J       Date:  1987-08

4.  Progression of hypertrophic cardiomyopathy. A cross sectional echocardiographic study.

Authors:  S Domenicucci; E Lazzeroni; J Roelandt; F J ten Cate; W B Vletter; A C Arntzenius; S K Das
Journal:  Br Heart J       Date:  1985-04

5.  Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Authors:  Ewa-Lena Bratt; Ingegerd Östman-Smith
Journal:  Cardiol Young       Date:  2014-03-10       Impact factor: 1.093

Review 6.  Autosomal dominant polycystic kidney disease combined with hypertrophic cardiomyopathy: A case report.

Authors:  Yingjing Shen; Chenggang Xu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

7.  Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy.

Authors:  Davood Javidgonbadi; Bert Andersson; Nils-Johan Abdon; Maria Schaufelberger; Ingegerd Östman-Smith
Journal:  Open Heart       Date:  2019-06-27

Review 8.  Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.

Authors:  Begum Yetis Sayin; Ali Oto
Journal:  Cardiol Ther       Date:  2022-03-30

9.  Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction.

Authors:  Yumin Li; Jia Liu; Yukun Cao; Yue Cui; Heshui Shi; Xiaoyu Han; Guozhu Shao; Xiaoyue Zhou; Jin Gu; Tong Liu
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.